Research raises possibility of effective, quick and reliable new test for bladder cancer
(Medical Xpress)—Research carried out at the University of Dundee has raised hopes of developing a quicker and more reliable new method of detecting urinary bladder cancer at an earlier stage.
A team from the University's School of Medicine, led by Dr Ghulam Nabi, has found that a process known as Raman spectroscopy (RS) has shown substantive promise in diagnosing bladder cancer.
At present, the most reliable way to test for this type of cancer is to carry out a biopsy on tissue removed from the patient's bladder. Possible side-effects include bleeding, discomfort and infection, while patient's currently face a two-week wait for the result of the biopsy.
RS is a spectroscopic technique used to study systems such as human tissue. A laser in RS equipment can detect changes in the structure of the tissue by measuring interactions, something with significant potential for diagnosing cancer at an early stage.
They found a correlation of more than 90 per cent in the results, suggesting that RS has potential to be used to make less-invasive and quicker diagnoses. As conclusions can be drawn instantly following the procedure, it may be possible to reduce the anxiety for patients awaiting the result of their test.
Dr Nabi said that, while the research was still at an early stage, the early results showed great promise for developing a new test for bladder cancer in future.
"Obviously, the earlier we diagnose cancer, the better the prognosis is for the patient," he said. "There are some specific difficulties in making a reliable early diagnosis of bladder cancer, and very often it is not diagnosed until the cancer has manifested itself as a variety of symptoms.
"What we have been looking to do is develop and early and reliable diagnosis of urinary bladder cancer. Raman spectroscopy tells us about technical structure of tissue before morphological changes in structure happen as a result of the cancer developing.
"The time that passes between a patient having a biopsy and receiving their results is an extremely anxious one for patients and their families. We believe that RS can remove this anxiety by providing a quick diagnosis and our results so far show that it does indeed show potential as a reliable tool for diagnosis.
"What we need to do now is expand our study population and refine the process until it is as reliable as biopsy but without the negative side-effects."
RS is named after the Indian Nobel Laureate Sir C.V Raman, whose 1928 work on the changes in the wavelength of light paved the way for the development of the technique. It has been used in various applications in chemistry for decades, and it has long been believed to hold potential for non-intrusive diagnosis of cancer.
A previous effort into the use of RS to diagnose bladder cancer was made some years ago but the probe inserted into the bladders of patients was unable to distinguish between cancer and inflammation. Dr Nabi's team build a more powerful probe with increased specifications which appears to be more effective.
The study, which appears in the edition of Analytical & Biological Chemistry published today, examined 14 patients who presented with symptoms of bladder cancer. The diagnosis made using RS was consistent with the biopsy results in 13 cases. Analysis of the results took place at MIT and the Norwegian University of Science.
Having proved the concept, Dr Nabi says the team will concentrate on creating a new probe for use in a far more extensive study.
"The next stage is to make a telescopic probe which we can insert into the bladder and that will tell us whether or not the patient is suffering from cancer as soon as it touches the tissue.
"We will need to look at a much bigger study population to see whether these very promising results translate but we are encouraged by what we have seen so far. If we can devise a probe reliable enough to remove the need for a biopsy this would allow us to diagnose cancer at a much earlier stage. It would also reduce the cost of carrying out a biopsy and then treating cancer at an advanced stage.
"Most importantly, it can improve the outcome for patients, reduce the complications that can arise from a biopsy and dispense with the lengthy wait for their results."
The research was supported by NHS Tayside's Endowment Funds.
In another study involving Dr Nabi recently, he and colleagues from Cambridge University explored whether it was possible to improve another of the tests for bladder cancer.
Patients with the disease pass cancer cells in their urine, and it is likely that anyone presenting with the symptoms will have a sample examined under a microscope before possibly being referred for a biopsy.
The problem is that the results are not definitive, and a significant variation exists between the interpretations of individual pathologists. The Cambridge/Dundee team proved that diagnosis can be made much more reliable by staining cells with an antibody-stained to mini microchromosomal protein prior to the test.
The antibody then sticks to the cancer cells, making them more visible as markers when looked at under the microscope.
Provided by University of Dundee
- New diagnostic test for bladder cancer Jun 25, 2010 | not rated yet | 0
- Gene test shows which bladder cancer patients may have cancer spread Jan 20, 2011 | not rated yet | 0
- New imaging agent has an appetite for dangerous prostate tumors Dec 08, 2011 | not rated yet | 0
- Some diabetes drugs may increase risk of bladder cancer Jul 03, 2012 | not rated yet | 0
- Selenium may prevent high risk-bladder cancer Dec 08, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer May 24, 2013 | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer May 24, 2013 | 5 / 5 (1) | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer May 24, 2013 | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer May 24, 2013 | 5 / 5 (2) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer May 24, 2013 | 5 / 5 (4) | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
18 hours ago | 5 / 5 (5) | 5
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
10 hours ago | not rated yet | 1
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
18 hours ago | 5 / 5 (1) | 1
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
18 hours ago | not rated yet | 0
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
18 hours ago | not rated yet | 0